← Back to All Stocks

WST - West Pharmaceutical Services

Health Care
Dividend Aristocrat

Price History

About

Industry

Medical Instruments & Supplies

Employees

10,800

Headquarters

United States


Company Overview

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

Price

$250.64

52-Week Range

$187 $322

Dividend Yield

0.36%

Dividend Score

C

Dividend

Yield 0.36%
Annual $0.88
Payout 13%
5Y Avg 0.25%

Valuation

P/E (TTM) 36.1
Fwd P/E 28.3
P/B 5.68
PEG 3.43

Profitability

Profit Margin 16.1%
Op Margin 21.6%
ROE 16.9%
ROA 10.1%

Financial Health

Current Ratio 3.02
Quick Ratio 2.10
Debt/Equity 10%

Cash Flow

Free CF $274M
Op CF $755M
Total Cash $791M

Analyst Consensus

Buy

13 analysts

Target: $317 $265 - $375
+26.4% implied

Dividend Growth

Most Recent Annual Growth

4.94%

3-Year Avg Growth

5.20%

5-Year Avg Growth

5.51%

Annual Dividends

Year-over-Year Growth

Recent Dividend History

Ex-Dividend Date Amount
Apr 29, 2026 $0.2200
Jan 28, 2026 $0.2200
Nov 12, 2025 $0.2200
Jul 30, 2025 $0.2100
Apr 30, 2025 $0.2100
Feb 07, 2025 $0.2100
Nov 13, 2024 $0.2100
Jul 31, 2024 $0.2000
Apr 23, 2024 $0.2000
Jan 30, 2024 $0.2000
Nov 07, 2023 $0.2000
Jul 25, 2023 $0.1900
Apr 25, 2023 $0.1900
Jan 24, 2023 $0.1900
Nov 08, 2022 $0.1900
Jul 19, 2022 $0.1800
Apr 19, 2022 $0.1800
Jan 18, 2022 $0.1800
Nov 09, 2021 $0.1800
Jul 20, 2021 $0.1700

Unlock Full Access

Get unlimited access to all features including our powerful dividend screener, detailed stock analysis, and our dividend growth forecasting tool.

Full Screener

300+ proven dividend growth stocks

Growth Forecasts

Project returns with reinvestment

Deep Analysis

Fundamentals & metrics that matter